HomeENTA • NASDAQ
add
Enanta Pharmaceuticals Inc
Previous close
$13.06
Day range
$12.06 - $13.02
Year range
$8.08 - $28.25
Market cap
256.91M USD
Avg Volume
145.50K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 17.05M | -4.16% |
Operating expense | 49.82M | -12.97% |
Net income | -31.16M | 17.26% |
Net profit margin | -182.70 | 13.67% |
Earnings per share | -1.47 | 17.88% |
EBITDA | -32.14M | 17.39% |
Effective tax rate | 1.15% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 300.31M | 42.95% |
Total assets | 413.56M | 26.69% |
Total liabilities | 247.44M | 333.58% |
Total equity | 166.11M | — |
Shares outstanding | 21.18M | — |
Price to book | 1.67 | — |
Return on assets | -19.46% | — |
Return on capital | -20.40% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -31.16M | 17.26% |
Cash from operations | -28.60M | -107.51% |
Cash from investing | 58.62M | 25.36% |
Cash from financing | -6.41M | -216.43% |
Net change in cash | 23.61M | -23.73% |
Free cash flow | -18.71M | -479.53% |
About
Founded
1995
Headquarters
Website
Employees
145